Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Future treatment of bone metastases
Allan Lipton
, Berenson
, Roodman
, Clohisy
, Guise
, Coleman
, Boyce
, Body
, Smith
Department of Medicine
Penn State Cancer Institute
Division of Hematology and Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
67
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Future treatment of bone metastases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bone Loss
25%
Bone Marrow Microenvironment
25%
Bone Matrix
25%
Bone Metastasis
100%
Bone Resorption
25%
Bone Surface
25%
Bone-directed Therapy
25%
Cytokine Factors
25%
Growth Factors
25%
Multiple Sites
25%
New Agents
50%
New Bone
50%
Osteoblast
50%
Osteoclast
100%
Osteoclast Differentiation
25%
Osteoclast Function
25%
Osteolysis
25%
Osteolytic Bone Lesions
25%
Osteolytic Metastasis
25%
Patient Quality of Life
25%
Patients with Cancer
25%
Skeletal-related Events
25%
Tumor
25%
Tumor Cells
25%
Tumor Growth
25%
Vicious Cycle
25%
Medicine and Dentistry
Bone Lesion
20%
Bone Marrow Microenvironment
20%
Bone Matrix
20%
Bone Metastasis
100%
Cancer
20%
Cytokine
40%
Growth Factor
20%
Neoplasm
20%
Osteoblast
40%
Osteoclast
100%
Osteoclastogenesis
20%
Osteolysis
60%
Quality of Life
20%
Skeleton
20%
Targeted Therapy
20%
Tumor Cell
20%
Tumor Progression
20%
Immunology and Microbiology
Bone Marrow Microenvironment
20%
Bone Matrix
20%
Cytokine
40%
Growth Factor
20%
Osteoblast
40%
Osteoclast
100%
Osteoclastogenesis
20%
Osteolysis
60%
Skeleton
20%
Tumor Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Lesion
33%
Bone Metastasis
100%
Cytokine
66%
Growth Factor
33%
Neoplasm
66%
Tumor Growth
33%
Biochemistry, Genetics and Molecular Biology
Cytokine
40%
Growth Factor
20%
Osteoblast
40%
Osteoclast
100%
Osteoclastogenesis
20%
Osteolysis
60%
Targeted Therapy
20%
Tumor Progression
20%